US Patent 8309550 Kinase inhibitors and their use as pharmaceutical agents
Patent 8309550 was granted and assigned to Shanghai Genomics, Inc. on November, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08309550 Kinase inhibitors and their use as pharmaceutical agents US Patent 8309550 Kinase inhibitors and their use as pharmaceutical agents
Infobox
Patent Number
0830955000
Patent Number
830955000
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083095500
Date of Patent
November 13, 2012
0Patent Application Number
130955260
Date Filed
April 27, 2011
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083095500
Date of Patent
November 13, 2012
0Patent Application Number
130955260
Date Filed
April 27, 2011
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08309550 Kinase inhibitors and their use as pharmaceutical agents
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08309550
Date of patent
November 13, 2012
Patent application number
13095526
Date Filed
April 27, 2011
Patent primary examiner
Find more entities like US Patent 8309550 Kinase inhibitors and their use as pharmaceutical agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
